Teladoc Health Price to Book Ratio 2014-2024 | TDOC
Historical price to book ratio values for Teladoc Health (TDOC) over the last 10 years. The current price to book ratio for Teladoc Health as of February 21, 2025 is 1.45.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Teladoc Health Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-02-21 | 11.51 | 1.31 | |
| 2024-09-30 | 9.18 | $8.77 | 1.05 |
| 2024-06-30 | 9.78 | $8.78 | 1.11 |
| 2024-03-31 | 15.10 | $13.52 | 1.12 |
| 2023-12-31 | 21.55 | $13.96 | 1.54 |
| 2023-09-30 | 18.59 | $13.86 | 1.34 |
| 2023-06-30 | 25.32 | $13.92 | 1.82 |
| 2023-03-31 | 25.90 | $13.98 | 1.85 |
| 2022-12-31 | 23.65 | $14.17 | 1.67 |
| 2022-09-30 | 25.35 | $37.32 | 0.68 |
| 2022-06-30 | 33.21 | $37.58 | 0.88 |
| 2022-03-31 | 72.13 | $56.63 | 1.27 |
| 2021-12-31 | 91.82 | $99.99 | 0.92 |
| 2021-09-30 | 126.81 | $99.91 | 1.27 |
| 2021-06-30 | 166.29 | $100.34 | 1.66 |
| 2021-03-31 | 181.75 | $102.52 | 1.77 |
| 2020-12-31 | 199.96 | $105.69 | 1.89 |
| 2020-09-30 | 219.24 | $26.45 | 8.29 |
| 2020-06-30 | 190.84 | $16.37 | 11.66 |
| 2020-03-31 | 155.01 | $13.50 | 11.48 |
| 2019-12-31 | 83.72 | $13.94 | 6.01 |
| 2019-09-30 | 67.72 | $13.73 | 4.93 |
| 2019-06-30 | 66.41 | $13.94 | 4.76 |
| 2019-03-31 | 55.60 | $14.02 | 3.97 |
| 2018-12-31 | 49.57 | $14.37 | 3.45 |
| 2018-09-30 | 86.35 | $14.68 | 5.88 |
| 2018-06-30 | 58.05 | $10.88 | 5.34 |
| 2018-03-31 | 40.30 | $8.85 | 4.56 |
| 2017-12-31 | 34.85 | $9.08 | 3.84 |
| 2017-09-30 | 33.15 | $7.85 | 4.22 |
| 2017-06-30 | 34.70 | $7.29 | 4.76 |
| 2017-03-31 | 25.00 | $6.32 | 3.96 |
| 2016-12-31 | 16.50 | $5.00 | 3.30 |
| 2016-09-30 | 18.31 | $5.26 | 3.48 |
| 2016-06-30 | 16.02 | $3.92 | 4.08 |
| 2016-03-31 | 9.60 | $4.27 | 2.25 |
| 2015-12-31 | 17.96 | $4.64 | 3.87 |
| 2015-09-30 | 22.29 | $5.01 | 4.45 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.185B | $2.602B |
| Teladoc Health, Inc. provides virtual access to high-quality care and expertise with a portfolio of services and solutions, covering medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company combines the latest in data and analytics with an award-winning user experience through a highly flexible technology platform. The company provides access to healthcare through its portfolio of five consumer brands 24 hours a day, seven days a week and 365 days a year. Its solutions are delivered with an approximate median response time of less than ten minutes in the United States for general medical inquiries from the time a member requests a general medical telehealth visit to the time they consult with a Teladoc Health network provider. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $150.197B | 27.76 |
| Elevance Health (ELV) | United States | $90.566B | 11.84 |
| CVS Health (CVS) | United States | $82.065B | 12.01 |
| Cencora (COR) | United States | $47.211B | 17.13 |
| DiDi Global (DIDIY) | China | $23.282B | 0.00 |
| Natera (NTRA) | United States | $22.205B | 0.00 |
| ICON (ICLR) | Ireland | $16.651B | 14.81 |
| BioMerieux (BMXMF) | France | $14.074B | 0.00 |
| Doximity (DOCS) | United States | $14.002B | 72.82 |
| Revvity (RVTY) | United States | $13.962B | 23.41 |
| Viatris (VTRS) | United States | $13.201B | 4.07 |
| Solventum (SOLV) | United States | $12.870B | 0.00 |
| Avantor (AVTR) | United States | $11.909B | 17.49 |
| CochLear (CHEOY) | Australia | $11.330B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.506B | 27.30 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.794B | 0.00 |
| HealthEquity (HQY) | United States | $9.682B | 48.57 |
| Sonic Healthcare (SKHHY) | Australia | $8.686B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.297B | 15.72 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.601B | 25.63 |
| Organon (OGN) | United States | $4.041B | 4.12 |
| Sotera Health (SHC) | United States | $3.829B | 20.49 |
| BrightSpring Health Services (BTSG) | United States | $3.552B | 75.56 |
| Surgery Partners (SGRY) | United States | $3.263B | 37.20 |
| Concentras Parent (CON) | United States | $2.981B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.791B | 338.60 |
| Alignment Healthcare (ALHC) | United States | $2.755B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.118B | 0.00 |
| Progyny (PGNY) | United States | $2.033B | 41.17 |
| PACS (PACS) | United States | $2.010B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.852B | 48.60 |
| Premier (PINC) | United States | $1.726B | 11.05 |
| Agilon Health (AGL) | United States | $1.492B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.480B | 12.40 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| CareDx (CDNA) | United States | $1.254B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.984B | 7.81 |
| Establishment Labs Holdings (ESTA) | $0.981B | 0.00 | |
| Embecta (EMBC) | United States | $0.838B | 5.74 |
| Auna S.A (AUNA) | Luxembourg | $0.611B | 0.00 |
| DocGo (DCGO) | United States | $0.513B | 19.35 |
| SBC Medicals (SBC) | United States | $0.483B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.480B | 0.00 |
| MultiPlan (MPLN) | United States | $0.477B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.453B | 0.00 |
| Enhabit (EHAB) | United States | $0.424B | 36.70 |
| Nutex Health (NUTX) | United States | $0.335B | 0.00 |
| LifeMD (LFMD) | United States | $0.326B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.311B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.294B | 7.71 |
| Beauty Health (SKIN) | United States | $0.199B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.183B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.144B | 0.00 |
| Biodesix (BDSX) | United States | $0.134B | 0.00 |
| So-Young (SY) | China | $0.114B | 19.40 |
| IceCure Medical (ICCM) | Israel | $0.083B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
| ModivCare (MODV) | United States | $0.079B | 4.29 |
| Oncology Institute (TOI) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.62 |
| Singular Genomics Systems (OMIC) | United States | $0.051B | 0.00 |
| OncoCyte (OCX) | United States | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.019B | 0.00 |
| KindlyMD (KDLY) | United States | $0.018B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |